VERNON HILLS, Ill.--(BUSINESS WIRE)--Applied NeuroSolutions, Inc. (OTC BB:APNS) (www.appliedneurosolutions.com), a Company focused on the development of an integrated portfolio of products for the treatment and diagnosis of Alzheimer’s disease (AD), today announced Dr. Peter Davies, its founding scientist, and the Judith and Burton P. Resnick Professor of Alzheimer’s Disease Research at Albert Einstein College of Medicine (AECOM), will be participating on an expert panel on Alzheimer’s disease hosted by Credit Suisse on December 14, 2007 at 10:00 a.m. eastern time.
